The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence (AI)-powered evaluation of protein drug-targetability through subcellular-level expression profiling from immunohistochemistry (IHC) images.
 
Sukjun Kim
Employment - Lunit
 
Jimin Moon
Employment - Lunit
 
Hosik Kim
Employment - Lunit
 
Chaekyung Lee
Employment - lunit
 
Sanghoon Song
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Jeongun Ryu
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Biagio Brattoli
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Patent of AI for healthcare technology failed by Lunit. I don't receive royalty from this patent.
Travel, Accommodations, Expenses - Lunit
 
Keunhyung Chung
Employment - Lunit
 
Taebum Lee
Employment - Lunit
 
Chang Ho Ahn
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Deep learning model of IHC images providing single cell level continuous quantification of target expression
 
Siraj Ali
Employment - EQRX; EQRX (I); lunit
Leadership - Droplet Biosciences; Elevation Oncology; Incysus; Pillar Biosciences; Promunity Tx
Stock and Other Ownership Interests - Exelixis; Merus NV; Pfizer; Pfizer
Consulting or Advisory Role - Nexo TX; SRone
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I)
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - De novo biotherapeutics; GCCELL; Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics